The goal of this clinical trial is to investigate if Mentalization-based therapy (MBT) is superior to enhanced usual care (treatment-as-usual-plus (TAU-plus)) for adolescents with disruptive behavior or dissocial disorders.
MBT is an intervention that aims to improve mentalizing. Mentalizing is the ability to reflect on mental states in oneself and others that motivate behavior. TAU-plus consists of psychiatric care for the adolescent, along with additional emotion-focused skills training for the parents.
Participants will be randomized in one of two groups using one study center.
Primary diagnosis of Oppositional defiant disorder (ODD) / Conduct-dissocial disorder (CDD) (ICD-11: 6C90-6C91; ICD-10: F91.0-F91.9; DSM-5: 312.81, 313.81)
Aged 12 to 19 years
Living with their parents
Provide written informed consent (plus parental consent for minors)
Severe acute substance dependence requiring inpatient detoxification
Acute psychotic symptoms or early-onset schizophrenia
Neurological impairments or intellectual disability (IQ < 80)
Insufficient proficiency in German
University Hospital Heidelberg
Lead sponsor
Vereinigung für analytische und tiefenpsychologisch fundierte Kinder- & Jugendlichen- Psychotherapie
Collaborator